The effect of short-term, high glucose concentration on endothelial cells and leukocytes in a 3D in vitro humanvascular tissue model

In Vitro Cellular and Developmental Biology - Animal

Volumn 45, Issue 5-6, 2009, Pages 234-242

  Gappa Fahlenkamp, H ^a   Shukla, A S ^a  

^a Oklahoma State University   (United States)

Author keywords

3D tissue model; Atherosclerosis; Diabetes; Endothelial cells; Leukocytes

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BLOOD VESSEL; CATTLE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; LEUKOCYTE; MACROPHAGE; METABOLISM; MONOCYTE; ORGAN CULTURE TECHNIQUE; T LYMPHOCYTE; TIME; UMBILICAL VEIN;

ANIMALS; ANTIGENS, CD14; ANTIGENS, CD3; BLOOD VESSELS; CATTLE; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; E-SELECTIN; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MACROPHAGES; MODELS, BIOLOGICAL; MONOCYTES; ORGAN CULTURE TECHNIQUES; T-LYMPHOCYTES; TIME FACTORS; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 67449097125     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-008-9171-4     Document Type: Article

References (31)

1. Altannavch, T. S.; Roubalova, K.; Kucera, P.; Andel, M. Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation.Physiol. Res. 53: 77-82; 2004.
2. Baumgartner-Parzer, S. M.; Wagner, L.; Pettermann, M.; Gessl, A.; Waldhausl, W. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia 38: 1367- 1370; 1995. doi:10.1007/BF00401771.
3. Bevilacqua, M. P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11: 767-804; 1993. doi:10.1146/annurev.iy. 11.040193.004003.
4. Blankenberg, S.; Barbaux, S.; Tiret, L. Adhesion molecules and atherosclerosis. Atherosclerosis 170: 191-203; 2003. doi:10.1016/S0021-9150(03) 00097-2.
5. Chia, M. C. The role of adhesion molecules in atherosclerosis. Crit. Rev. Clin. Lab. Sci. 35: 573-602; 1998. doi:10.1080/ 10408369891234282.
6. Cybulsky, M. I.; Gimbrone, M. A. Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251: 788-791; 1991. doi:10.1126/science.1990440.
7. Gerrity, R. G. The role of the monocyte in atherogenesis: 1. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103: 181-190; 1981.
8. Hansson, G. K.; Holm, J.; Jonasson, L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135: 169-175; 1989.
9. Jonasson, L.; Holm, J.; Skalli, O.; Bondjers, G.; Hansson, G. K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6: 131-138; 1986.
10. Kim, J. A.; Berliner, J. A.; Natarajan, R. D.; Nadler, J. L. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes 43: 1103-1107; 1994. doi:10.2337/ diabetes.43.9.1103.
11. Kume, N.; Cybulsky, M. I.; Gimbrone, M. A. Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90: 1138- 1144; 1992. doi:10.1172/JCI115932.
12. Li, H.; Cybulsky, M. I.; Gimbrone, M. A. Jr.; Libby, P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 13: 197-204; 1993.
13. Lidington, E. A.; Moyes, D. L.; McCormack, A. M.; Rose, M. L. A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transpl. Immunol. 7: 239- 246; 1999. doi:10.1016/S0966-3274(99)80008-2.
14. Manduteanu, I.; Voinea, M.; Serban, G.; Simionescu, M. High glucose induces enhanced monocyte adhesion to valvular endothelial cells via a mechanism involving ICAM-1, VCAM-1 and CD18. Endothelium 6: 315-324; 1999. doi:10.3109/10623329909 078498.
15. Morigi, M.; Angioletti, S.; Imberti, B.; Donadelli, R.; Micheletti, G.; Figliuzzi, M.; Remuzzi, A.; Zoja, C.; Remuzzi, G. Leukocyteendothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J. Clin. Invest. 101: 1905-1915; 1998. doi:10.1172/JCI656.
16. Nakashima, Y.; Raines, E. W.; Plump, A. S.; Breslow, J. L.; Ross, R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-pronesites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18: 842-851; 1998.
17. Nathan, D. M. Long-term complications of diabetes mellitus. N. Engl. J. Med. 328: 1676-1685; 1993. doi:10.1056/NEJM199306103282306.
18. Piconi, L.; Quagliaro, L.; Da Ros, R.; Assaloni, R.; Giugliano, D.; Esposito, K.; Szabo, C.; Ceriello, A. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J. Thromb. Haemost. 2: 1453- 1459; 2004. doi:10.1111/j.1538-7836.2004.00835.x.
19. Piga, R.; Naito, Y.; Kokura, S.; Handa, O.; Yoshikawa, T. Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis 193: 328-334; 2007. doi:10.1016/j.atherosclerosis.2006.09.016.
20. Puente Navazo, M. D.; Chettab, K.; Duhault, J.; Koenig-Berard, E.; McGregor, J. L. Glucose and insulin modulate the capacity of endothelial cells (HUVEC) to express P-selectin and bind a monocytic cell line (U937). Thromb. Haemost. 86: 680-685; 2001.
21. Ross, R. The pathogenesis of atherosclerosis - an update. N. Engl. J. Med. 314: 488-500; 1986.
22. Steiner, G. Atherosclerosis, the major complication of diabetes. Adv. Exp. Med. Biol. 189: 277-297; 1985.
23. Stemme, S.; Holm, J.; Hansson, G. K. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler. Thromb. 12: 206-211; 1992.
24. Takami, S.; Yamashita, S.; Kihara, S.; Kameda-Takemura, K.; Matsuzawa, Y. High concentration of glucose induces the expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. Atherosclerosis 138: 35-41; 1998. doi:10.1016/S0021-9150(97)00286-4.
25. Taki, H.; Kashiwagi, A.; Tanaka, Y.; Horiike, K. Expression of intercellular adhesion molecules 1 (ICAM-1) via an osmotic effect in human umbilical vein endothelial cells exposed to high glucose medium. Life Sci. 58: 1713-1721; 1996. doi:10.1016/ 0024-3205(96)00151-8.
26. Turner, R.; Cull, C.; Holman, R. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 124: 136-145; 1996.
27. van der Wal, A. C.; Becker, A. E.; van der Loos, C. M.; Das, P. K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36-44; 1994.
28. van der Wal, A. C.; Das, P. K.; Bentz van de Berg, D.; van der Loos, C. M.; Becker, A. E. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab. Invest. 61: 166-170; 1989.
29. Walpola, P. L.; Gotlieb, A. I.; Cybulsky, M. I.; Langille, B. L. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler. Thromb. Vasc. Biol. 15: 2-10; 1995.
30. Watson, A. D.; Leitinger, N.; Navab, M.; Faull, K. F.; Horkko, S.; Witztum, J. L.; Palinski, W.; Schwenke, D.; Salomon, R. G.; Sha, W.; Subbanagounder, G.; Fogelman, A. M.; Berliner, J. A. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272: 13597-13607; 1997. doi:10.1074/jbc.272.21.13597.
31. Webster, M. W.; Scott, R. S. What cardiologists need to know about diabetes. Lancet 350Suppl 1: SI23-SI28; 1997. doi:10.1016/ S0140-6736(97)90025- 8.